VKTX: Viking Therapeutics Inc. Stocks News on December 21, 2024

Novo Crashes After Obesity Drug Misses Lofty Expectations. Lilly, Viking And Amgen Surge.

VKTX

Investor's Business Daily

10 hours ago

Novo Crashes After Obesity Drug Misses Lofty Expectations. Lilly, Viking And Amgen Surge.

Why Novo Nordisk Stock Got Destroyed Today, but Eli Lilly and Viking Stocks Are Up

VKTX

Motley Fool

14 hours ago

Why Novo Nordisk Stock Got Destroyed Today, but Eli Lilly and Viking Stocks Are Up

VKTX

MT Newswires

17 hours ago

Amgen, Eli Lilly, Viking Therapeutics Shares Rise Pre-Bell After Novo Nordisk's Obesity Treatment Falls Short of Expectations

Novo Crashes 20% After New Obesity Drug Misses Forecasts. Lilly, Viking, Amgen Jump.

VKTX

Investor's Business Daily

17 hours ago

Novo Crashes 20% After New Obesity Drug Misses Forecasts. Lilly, Viking, Amgen Jump.

Merck Enters Obesity Space, Buys Rights to Hansoh's Oral GLP-1 Drug

VKTX

Zacks

2 days ago

Merck Enters Obesity Space, Buys Rights to Hansoh's Oral GLP-1 Drug

VKTX

Simply Wall St.

2 days ago

Companies Like Viking Therapeutics (NASDAQ:VKTX) Can Afford To Invest In Growth

VKTX

Zacks

2 days ago

Here's Why VKTX Stock Plummeted 18% on Wednesday

Viking Plummets After Merck Inks A $2.01 Billion Obesity Deal — With Someone Else

VKTX

Investor's Business Daily

2 days ago

Viking Plummets After Merck Inks A $2.01 Billion Obesity Deal — With Someone Else

VKTX

Insider Monkey

3 days ago

Why Viking Therapeutics (VKTX), HEICO Corporation (HEI), and ABM Industries (ABM) Stocks Are Plunging Today?

What's Going On With Viking Therapeutics Stock On Wednesday?

VKTX

Benzinga

3 days ago

What's Going On With Viking Therapeutics Stock On Wednesday?

Merck Licenses a Weight-Loss Pill. It’s Bad News for Obesity Biotechs.

VKTX

Barrons.com

3 days ago

Merck Licenses a Weight-Loss Pill. It’s Bad News for Obesity Biotechs.

VKTX

Insider Monkey

4 days ago

Is Viking Therapeutics, Inc. (VKTX) the Best Weight Loss Stock to Buy Now According to Hedge Funds?

Battle Over Weight-Loss Drugs: Can Eli Lilly, Novo Nordisk Defend Their Turf?

VKTX

Investor's Business Daily

5 days ago

Battle Over Weight-Loss Drugs: Can Eli Lilly, Novo Nordisk Defend Their Turf?

Prediction: These Could Be the Best-Performing Pharma and Biotech Stocks Through 2030

VKTX

Motley Fool

5 days ago

Prediction: These Could Be the Best-Performing Pharma and Biotech Stocks Through 2030

2 Soaring Stocks That Could Climb 68% to 166% Higher in 2025, According to Wall Street

VKTX

Motley Fool

6 days ago

2 Soaring Stocks That Could Climb 68% to 166% Higher in 2025, According to Wall Street

VKTX

Zacks

7 days ago

Viking Therapeutics, Inc. (VKTX) Stock Moves -1.75%: What You Should Know

Warning: This Skyrocketing Stock Has a Hidden Risk

VKTX

Motley Fool

11 days ago

Warning: This Skyrocketing Stock Has a Hidden Risk

Should You Forget Pfizer and Buy These Unstoppable Stocks Instead?

VKTX

Motley Fool

16 days ago

Should You Forget Pfizer and Buy These Unstoppable Stocks Instead?

After Crashing 27% in the Past Month, Is Viking Therapeutics Stock a Bargain Buy Right Now?

VKTX

Motley Fool

18 days ago

After Crashing 27% in the Past Month, Is Viking Therapeutics Stock a Bargain Buy Right Now?

2 Disruptive Growth Stocks With Room to Run

VKTX

Motley Fool

18 days ago

2 Disruptive Growth Stocks With Room to Run

VKTX

MT Newswires

19 days ago

Piper Sandler Initiates Viking Therapeutics at Overweight

Here's Yet Another Reason to Buy Viking Therapeutics Stock Like There's No Tomorrow

VKTX

Motley Fool

23 days ago

Here's Yet Another Reason to Buy Viking Therapeutics Stock Like There's No Tomorrow

Amgen Dives 5% Despite 'Truly Remarkable' Results For Obesity Treatment

VKTX

Investor's Business Daily

24 days ago

Amgen Dives 5% Despite 'Truly Remarkable' Results For Obesity Treatment

Amgen Obesity Drug Falls Short of Efficacy Expectations in Trial, Mizuho Says; Shares Decline

VKTX

MT Newswires

24 days ago

Amgen Obesity Drug Falls Short of Efficacy Expectations in Trial, Mizuho Says; Shares Decline

Amgen Crashes 9% Despite 'Truly Remarkable' Results For Obesity Treatment

VKTX

Investor's Business Daily

25 days ago

Amgen Crashes 9% Despite 'Truly Remarkable' Results For Obesity Treatment

Billionaire Ken Griffin Invested $93 Million of Citadel's Portfolio in a Stock That Could Rocket 105% Higher, According to a Wall Street Analyst

VKTX

Motley Fool

a month ago

Billionaire Ken Griffin Invested $93 Million of Citadel's Portfolio in a Stock That Could Rocket 105% Higher, According to a Wall Street Analyst

VKTX

Motley Fool

a month ago

3 Monster Stocks in the Making

RFK Jr. Spooks Weight-Loss Stocks. Should Eli Lilly, Novo Nordisk Be Worried?

VKTX

Investor's Business Daily

a month ago

RFK Jr. Spooks Weight-Loss Stocks. Should Eli Lilly, Novo Nordisk Be Worried?

VKTX

Zacks

a month ago

Why Is Viking Therapeutics (VKTX) Down 29.5% Since Last Earnings Report?

VKTX

Zacks

a month ago

VKTX Stock Loses Over $1B in a Month: How to Play the Stock?

VKTX

MT Newswires

a month ago

B. Riley Initiates Viking Therapeutics at Buy With $109 Price Target

VKTX

Insider Monkey

a month ago

Do Redditors Think That Viking Therapeutics Inc. (VKTX) Has a Big Upside Potential?

Viking Therapeutics Garners Analyst Support For NASH And Metabolic Programs

VKTX

Benzinga

a month ago

Viking Therapeutics Garners Analyst Support For NASH And Metabolic Programs

VKTX

MT Newswires

a month ago

Viking Therapeutics Phase 2b Trial Into Non-Alcoholic Steatohepatitis Meets Primary, Secondary Endpoints

Viking Therapeutics Presents Results from Phase 2b VOYAGE Study of VK2809 in Biopsy-Confirmed NASH/MASH at the 75th Liver Meeting® 2024

VKTX

PR Newswire

a month ago

Viking Therapeutics Presents Results from Phase 2b VOYAGE Study of VK2809 in Biopsy-Confirmed NASH/MASH at the 75th Liver Meeting® 2024

3 Things You Need to Know if You Buy Viking Therapeutics Today

VKTX

Motley Fool

a month ago

3 Things You Need to Know if You Buy Viking Therapeutics Today

Is It Too Late to Buy Viking Therapeutics Stock?

VKTX

Motley Fool

a month ago

Is It Too Late to Buy Viking Therapeutics Stock?

Prediction: Acquisitions Will Skyrocket Under The Trump Administration. Here's 1 Pharmaceutical Company I Have My Eyes On.

VKTX

Motley Fool

a month ago

Prediction: Acquisitions Will Skyrocket Under The Trump Administration. Here's 1 Pharmaceutical Company I Have My Eyes On.

Should You Forget Eli Lilly and Buy This Magnificent Biotech Stock Instead?

VKTX

Motley Fool

a month ago

Should You Forget Eli Lilly and Buy This Magnificent Biotech Stock Instead?

Amgen Rebounds. But Do Eli Lilly And Viking Therapeutics Now Have The Upper Hand?

VKTX

Investor's Business Daily

a month ago

Amgen Rebounds. But Do Eli Lilly And Viking Therapeutics Now Have The Upper Hand?

Did Viking Therapeutics Just Say "Checkmate" To Eli Lilly?

VKTX

Motley Fool

a month ago

Did Viking Therapeutics Just Say "Checkmate" To Eli Lilly?

Viking Therapeutics to Present Data from Phase 2b VOYAGE Study of VK2809 in Patients with Biopsy-Confirmed NASH/MASH at the 75th Liver Meeting® 2024

VKTX

PR Newswire

a month ago

Viking Therapeutics to Present Data from Phase 2b VOYAGE Study of VK2809 in Patients with Biopsy-Confirmed NASH/MASH at the 75th Liver Meeting® 2024

Is Viking Therapeutics a Buy on the Dip?

VKTX

Motley Fool

a month ago

Is Viking Therapeutics a Buy on the Dip?

4 Reasons Why Buying Viking Therapeutics Stock Right Now Is a Smart Move

VKTX

Motley Fool

a month ago

4 Reasons Why Buying Viking Therapeutics Stock Right Now Is a Smart Move

Got $5,000? Viking Therapeutics Stock Just Got a Big New Green Flag

VKTX

Motley Fool

a month ago

Got $5,000? Viking Therapeutics Stock Just Got a Big New Green Flag

Viking Therapeutics Offers An Obesity Drug for Healthy Adults

VKTX

GuruFocus.com

2 months ago

Viking Therapeutics Offers An Obesity Drug for Healthy Adults

Viking stock fluctuates amid manufacturing concerns with obesity pill

VKTX

Clinical Trials Arena

2 months ago

Viking stock fluctuates amid manufacturing concerns with obesity pill

VKTX

Motley Fool

2 months ago

Is Viking Therepautics a Buy Now?

Why Viking Therapeutics Stock Plummeted After Soaring Today

VKTX

Motley Fool

2 months ago

Why Viking Therapeutics Stock Plummeted After Soaring Today

Viking Therapeutics Tumbles As Obesity Competition Sabotages Its Novo Nordisk Beat

VKTX

Investor's Business Daily

2 months ago

Viking Therapeutics Tumbles As Obesity Competition Sabotages Its Novo Nordisk Beat

Viking Therapeutics stock falling amid results for new GLP-1 pill

VKTX

Yahoo Finance Video

2 months ago

Viking Therapeutics stock falling amid results for new GLP-1 pill

These Stocks Are Moving the Most Today: Nvidia, Intel, Apple, Sherwin-Williams, Talen, Constellation Energy, DJT, Peloton, and More

VKTX

Barrons.com

2 months ago

These Stocks Are Moving the Most Today: Nvidia, Intel, Apple, Sherwin-Williams, Talen, Constellation Energy, DJT, Peloton, and More

Stocks to Watch Monday: Trump Media, Viking Therapeutics, Nvidia, Intel

VKTX

The Wall Street Journal

2 months ago

Stocks to Watch Monday: Trump Media, Viking Therapeutics, Nvidia, Intel

Viking Therapeutics' Hot Stock Slips After Latest Obesity Drug Trial Results

VKTX

Investopedia

2 months ago

Viking Therapeutics' Hot Stock Slips After Latest Obesity Drug Trial Results

A new weight loss pill outperformed Novo Nordisk's version

VKTX

Quartz

2 months ago

A new weight loss pill outperformed Novo Nordisk's version

Viking Therapeutics, Roblox, Trump Media: 3 Stocks In Focus

VKTX

Yahoo Finance Video

2 months ago

Viking Therapeutics, Roblox, Trump Media: 3 Stocks In Focus

This Pharma Stock Is Rising. The Weight-Loss Drugs Race Has Widened Beyond Lilly, Novo.

VKTX

Barrons.com

2 months ago

This Pharma Stock Is Rising. The Weight-Loss Drugs Race Has Widened Beyond Lilly, Novo.

Viking Therapeutics Tops Novo Nordisk As Obesity Pill Brawl Continues

VKTX

Investor's Business Daily

2 months ago

Viking Therapeutics Tops Novo Nordisk As Obesity Pill Brawl Continues

VKTX

MT Newswires

2 months ago

Oppenheimer Adjusts Viking Therapeutics Price Target to $164 From $138, Maintains Outperform Rating

Viking Therapeutics' Reveals Early-Stage From Experimental Oral Obesity Drug Showing Weight Loss And Safety

VKTX

Benzinga

2 months ago

Viking Therapeutics' Reveals Early-Stage From Experimental Oral Obesity Drug Showing Weight Loss And Safety

VKTX

MT Newswires

2 months ago

Viking Therapeutics Shares Advance Pre-Bell Amid New 'Positive' Data on VK2735 Studies

Nvidia to join Dow, election looms for Wall Street: Yahoo Finance

VKTX

Yahoo Finance Video

2 months ago

Nvidia to join Dow, election looms for Wall Street: Yahoo Finance

Big Pharma’s Obesity Bonanza Faces New Tests

VKTX

The Wall Street Journal

2 months ago

Big Pharma’s Obesity Bonanza Faces New Tests

Viking Therapeutics Reports New Data from VK2735 Obesity Program at ObesityWeek® 2024

VKTX

PR Newswire

2 months ago

Viking Therapeutics Reports New Data from VK2735 Obesity Program at ObesityWeek® 2024

Viking Therapeutics Surges, Set To Break Out On Latest Obesity Drug Data

VKTX

Investor's Business Daily

2 months ago

Viking Therapeutics Surges, Set To Break Out On Latest Obesity Drug Data

Madrigal Catapults After Novo's Wegovy Proves It's No 'Silver Bullet' In MASH

VKTX

Investor's Business Daily

2 months ago

Madrigal Catapults After Novo's Wegovy Proves It's No 'Silver Bullet' In MASH

Viking Therapeutics to Participate at Upcoming Investor Conferences

VKTX

PR Newswire

2 months ago

Viking Therapeutics to Participate at Upcoming Investor Conferences

This High-Flying Stock Just Became a Better Buy

VKTX

Motley Fool

2 months ago

This High-Flying Stock Just Became a Better Buy

Viking Therapeutics CFO Cashes Out: $10M in Shares Sold Amidst Stock Surge

VKTX

GuruFocus.com

2 months ago

Viking Therapeutics CFO Cashes Out: $10M in Shares Sold Amidst Stock Surge

Pfizer Unveils Its Next Black Box In Obesity. It's Taking On Amgen.

VKTX

Investor's Business Daily

2 months ago

Pfizer Unveils Its Next Black Box In Obesity. It's Taking On Amgen.

VKTX

MT Newswires

2 months ago

Viking Therapeutics Insider Sold Shares Worth $10,089,164, According to a Recent SEC Filing

Viking Therapeutics to Highlight Clinical Data from VK2735 Obesity Program in Presentations at ObesityWeek® 2024

VKTX

PR Newswire

2 months ago

Viking Therapeutics to Highlight Clinical Data from VK2735 Obesity Program in Presentations at ObesityWeek® 2024

VKTX

MT Newswires

2 months ago

Viking Therapeutics Insider Sold Shares Worth $1,272,000, According to a Recent SEC Filing

Could Buying This Weight Loss Stock Be Like Investing in Novo Nordisk At The Dawn of The GLP-1 Revolution?

VKTX

Motley Fool

2 months ago

Could Buying This Weight Loss Stock Be Like Investing in Novo Nordisk At The Dawn of The GLP-1 Revolution?

Why Viking Therapeutics Stock Soared by Nearly 21% on Thursday

VKTX

Motley Fool

2 months ago

Why Viking Therapeutics Stock Soared by Nearly 21% on Thursday

Viking Therapeutics stock soars on heels of Q3 beat

VKTX

Yahoo Finance Video

2 months ago

Viking Therapeutics stock soars on heels of Q3 beat

Viking Therapeutics Skyrockets After Dealing A Blow To Eli Lilly's Obesity Triplet

VKTX

Investor's Business Daily

2 months ago

Viking Therapeutics Skyrockets After Dealing A Blow To Eli Lilly's Obesity Triplet

Viking Therapeutics Soars 21%: Is This Obesity Drug the Next Blockbuster Weight Loss Treatment?

VKTX

GuruFocus.com

2 months ago

Viking Therapeutics Soars 21%: Is This Obesity Drug the Next Blockbuster Weight Loss Treatment?

VKTX

MT Newswires

2 months ago

Sector Update: Health Care Stocks Decline Thursday Afternoon

VKTX

Thomson Reuters StreetEvents

2 months ago

Q3 2024 Viking Therapeutics Inc Earnings Call

VKTX

MT Newswires

2 months ago

Update: Viking Therapeutics Shares Rise Following Q3 Results

How Viking Therapeutics Just Dealt A Blow To Eli Lilly's Obesity Triplet

VKTX

Investor's Business Daily

2 months ago

How Viking Therapeutics Just Dealt A Blow To Eli Lilly's Obesity Triplet

VKTX

Zacks

2 months ago

VKTX Beats on Q3 Earnings, Stock Up on Obesity Pipeline Advancements

3 Growth Stocks That Have Generated 1,000% Returns Since the Last Presidential Election (and They've All Outperformed Nvidia)

VKTX

Motley Fool

2 months ago

3 Growth Stocks That Have Generated 1,000% Returns Since the Last Presidential Election (and They've All Outperformed Nvidia)

VKTX

GuruFocus.com

2 months ago

Viking Therapeutics Inc (VKTX) Q3 2024 Earnings Call Highlights: Strong Financial Position Amid ...

VKTX

MT Newswires

2 months ago

Viking Therapeutics Q3 Loss Narrows -- Shares Rise After Hours

Viking Therapeutics Reports Third Quarter 2024 Financial Results and Provides Corporate Update

VKTX

PR Newswire

2 months ago

Viking Therapeutics Reports Third Quarter 2024 Financial Results and Provides Corporate Update

Viking Therapeutics Stock: Buy or Sell Before Q3 Earnings?

VKTX

Zacks

2 months ago

Viking Therapeutics Stock: Buy or Sell Before Q3 Earnings?

VKTX

Zacks

2 months ago

Viking Therapeutics, Inc. (VKTX) Exceeds Market Returns: Some Facts to Consider

State Street Corp's Strategic Reduction in Viking Therapeutics Holdings

VKTX

GuruFocus.com

2 months ago

State Street Corp's Strategic Reduction in Viking Therapeutics Holdings

Viking Stock Rises 29% in Three Months: Time to Buy, Hold or Sell?

VKTX

Zacks

2 months ago

Viking Stock Rises 29% in Three Months: Time to Buy, Hold or Sell?

Viking Therapeutics Gives Investors Another Reason to Remain Bullish on Its Future

VKTX

Motley Fool

2 months ago

Viking Therapeutics Gives Investors Another Reason to Remain Bullish on Its Future

VKTX

Zacks

2 months ago

Viking Therapeutics, Inc. (VKTX) Outpaces Stock Market Gains: What You Should Know

Viking Therapeutics to Report Financial Results for Third Quarter 2024 on October 23, 2024

VKTX

PR Newswire

2 months ago

Viking Therapeutics to Report Financial Results for Third Quarter 2024 on October 23, 2024

Why Amgen's Obesity Drug — And $5 Billion Opportunity — Led To A Downgrade

VKTX

Investor's Business Daily

2 months ago

Why Amgen's Obesity Drug — And $5 Billion Opportunity — Led To A Downgrade

VKTX

Zacks

2 months ago

Is It Worth Investing in Viking Therapeutics (VKTX) Based on Wall Street's Bullish Views?

Where Will Viking Therapeutics Be in 5 Years?

VKTX

Motley Fool

2 months ago

Where Will Viking Therapeutics Be in 5 Years?

Better Biotech Stock to Buy With $1,500 Right Now: Viking Therapeutics vs. Summit Therapeutics

VKTX

Motley Fool

2 months ago

Better Biotech Stock to Buy With $1,500 Right Now: Viking Therapeutics vs. Summit Therapeutics

VKTX

Simply Wall St.

2 months ago

With 74% institutional ownership, Viking Therapeutics, Inc. (NASDAQ:VKTX) is a favorite amongst the big guns

The Ultimate Biotech Stock to Buy With $100 Right Now

VKTX

Motley Fool

2 months ago

Latest Viking Therapeutics Inc. (VKTX) News on December 21, 2024

Share on Social Networks: